PL3288967T3 - Związek farmaceutyczny - Google Patents

Związek farmaceutyczny

Info

Publication number
PL3288967T3
PL3288967T3 PL16729054T PL16729054T PL3288967T3 PL 3288967 T3 PL3288967 T3 PL 3288967T3 PL 16729054 T PL16729054 T PL 16729054T PL 16729054 T PL16729054 T PL 16729054T PL 3288967 T3 PL3288967 T3 PL 3288967T3
Authority
PL
Poland
Prior art keywords
pharmaceutical compound
pharmaceutical
compound
Prior art date
Application number
PL16729054T
Other languages
English (en)
Inventor
Philippe Wolgen
Roland Callens
Original Assignee
Vallaurix Pte. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vallaurix Pte. Ltd. filed Critical Vallaurix Pte. Ltd.
Publication of PL3288967T3 publication Critical patent/PL3288967T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68Melanocyte-stimulating hormone [MSH]
    • C07K14/685Alpha-melanotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL16729054T 2015-04-28 2016-04-28 Związek farmaceutyczny PL3288967T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15165537.0A EP3088418A1 (en) 2015-04-28 2015-04-28 Pharmaceutical compound
PCT/IB2016/052416 WO2016174610A1 (en) 2015-04-28 2016-04-28 Pharmaceutical compound
EP16729054.3A EP3288967B1 (en) 2015-04-28 2016-04-28 Pharmaceutical compound

Publications (1)

Publication Number Publication Date
PL3288967T3 true PL3288967T3 (pl) 2020-05-18

Family

ID=53016525

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16729054T PL3288967T3 (pl) 2015-04-28 2016-04-28 Związek farmaceutyczny

Country Status (14)

Country Link
US (1) US20180086789A1 (pl)
EP (2) EP3088418A1 (pl)
JP (1) JP6795258B2 (pl)
KR (1) KR20180002720A (pl)
AU (1) AU2016255690B2 (pl)
CA (1) CA2983980A1 (pl)
DK (1) DK3288967T3 (pl)
ES (1) ES2769253T3 (pl)
PH (1) PH12017501979A1 (pl)
PL (1) PL3288967T3 (pl)
PT (1) PT3288967T (pl)
SG (1) SG11201708818VA (pl)
SI (1) SI3288967T1 (pl)
WO (1) WO2016174610A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3088417A1 (en) 2015-04-28 2016-11-02 Vallaurix Pte. Ltd. Pharmaceutical compound
CA3050630A1 (en) * 2017-02-01 2018-08-09 Clinuvel Pharmaceuticals Ltd Alpha-msh analogues used in the treatment of xeroderma pigmentosum

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100048A (en) * 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
WO2006012667A1 (en) 2004-08-04 2006-02-09 Clinuvel Pharmaceuticals Limited Methods of inducing melanogenesis in a subject.
EP2865422B1 (en) 2006-08-31 2017-10-18 Clinuvel Pharmaceuticals Limited Alpha-MSH derivatives for the treatment of photodermatoses
EP2487185A1 (en) * 2011-02-11 2012-08-15 Clinuvel Pharmaceuticals Limited Hexapeptide with improved activity in the repair of cellular DNA of dermal cells
GB201310921D0 (en) * 2013-06-19 2013-07-31 Chemical & Biopharmaceutical Lab Of Patras S A Peptide-resin conjugate and use thereof

Also Published As

Publication number Publication date
SI3288967T1 (sl) 2020-04-30
WO2016174610A1 (en) 2016-11-03
PT3288967T (pt) 2020-02-04
SG11201708818VA (en) 2017-11-29
AU2016255690B2 (en) 2020-03-26
US20180086789A1 (en) 2018-03-29
JP6795258B2 (ja) 2020-12-02
ES2769253T3 (es) 2020-06-25
CA2983980A1 (en) 2016-11-03
EP3288967A1 (en) 2018-03-07
KR20180002720A (ko) 2018-01-08
PH12017501979A1 (en) 2018-03-26
DK3288967T3 (da) 2020-02-10
EP3288967B1 (en) 2019-11-06
EP3088418A1 (en) 2016-11-02
AU2016255690A1 (en) 2017-12-07
JP2018515600A (ja) 2018-06-14

Similar Documents

Publication Publication Date Title
IL258213A (en) Pharmaceutical compounds
GB201511790D0 (en) Pharmaceutical compound
HUE052443T2 (hu) Gyógyszerészeti vegyületek
GB201612092D0 (en) Pharmaceutical compounds
GB201617758D0 (en) Pharmaceutical compounds
GB201419579D0 (en) Pharmaceutical compound
GB201414730D0 (en) Pharmaceutical compound
GB201506658D0 (en) Pharmaceutical compounds
IL258246A (en) Pharmaceutical compounds
GB201504675D0 (en) Pharmaceutical compounds
GB201519352D0 (en) Pharmaceutical compounds
GB201506660D0 (en) Pharmaceutical compounds
ZA201900540B (en) Pharmaceutical compounds
HUE052107T2 (hu) Gyógyszerészeti vegyületek
GB201617454D0 (en) Pharmaceutical compounds
GB201612095D0 (en) Pharmaceutical compounds
GB201516411D0 (en) Pharmaceutical compound
GB201506933D0 (en) Pharmaceutical compounds
GB201502567D0 (en) Pharmaceutical compounds
GB201617871D0 (en) Pharmaceutical compounds
SG11201708818VA (en) Pharmaceutical compound
GB201615912D0 (en) Pharmaceutical compound
GB201615916D0 (en) Pharmaceutical compound
SG11201708817XA (en) Pharmaceutical compound
HK1226067B (zh) 藥物化合物